A detailed history of Vanguard Group Inc transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,851,218 shares of AVIR stock, worth $15.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,851,218
Previous 4,724,405 2.68%
Holding current value
$15.7 Million
Previous $15.6 Million 3.93%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.17 - $4.02 $401,997 - $509,788
126,813 Added 2.68%
4,851,218 $16.3 Million
Q2 2024

Aug 13, 2024

BUY
$3.31 - $4.04 $6,232 - $7,607
1,883 Added 0.04%
4,724,405 $15.6 Million
Q1 2024

May 10, 2024

BUY
$3.09 - $4.56 $379,489 - $560,022
122,812 Added 2.67%
4,722,522 $19.1 Million
Q4 2023

Feb 14, 2024

BUY
$2.8 - $3.35 $73,556 - $88,004
26,270 Added 0.57%
4,599,710 $14 Million
Q3 2023

Nov 14, 2023

BUY
$3.0 - $3.79 $167,523 - $211,637
55,841 Added 1.24%
4,573,440 $13.7 Million
Q2 2023

Aug 14, 2023

SELL
$3.21 - $5.06 $223,358 - $352,084
-69,582 Reduced 1.52%
4,517,599 $16.9 Million
Q1 2023

May 15, 2023

SELL
$3.0 - $4.97 $4.51 Million - $7.47 Million
-1,502,341 Reduced 24.67%
4,587,181 $15.4 Million
Q4 2022

Feb 10, 2023

SELL
$4.35 - $6.17 $6.5 Million - $9.22 Million
-1,494,734 Reduced 19.71%
6,089,522 $29.3 Million
Q3 2022

Nov 14, 2022

BUY
$5.49 - $8.79 $2.22 Million - $3.55 Million
403,971 Added 5.63%
7,584,256 $43.2 Million
Q2 2022

Aug 12, 2022

BUY
$5.33 - $8.18 $2.4 Million - $3.69 Million
451,082 Added 6.7%
7,180,285 $51 Million
Q1 2022

May 13, 2022

BUY
$5.5 - $9.19 $5.21 Million - $8.71 Million
947,321 Added 16.38%
6,729,203 $48.6 Million
Q4 2021

Feb 14, 2022

BUY
$7.67 - $44.59 $4.62 Million - $26.8 Million
601,927 Added 11.62%
5,781,882 $51.7 Million
Q3 2021

Nov 12, 2021

BUY
$21.33 - $35.06 $13.7 Million - $22.6 Million
643,792 Added 14.19%
5,179,955 $182 Million
Q2 2021

Aug 13, 2021

BUY
$19.22 - $59.08 $87.2 Million - $268 Million
4,536,163 New
4,536,163 $97.4 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $270M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.